PMC · DOI:10.1016/j.gendis.2025.101944·November 19, 2025
Multi-omics Mendelian randomization to identify novel immune therapeutic targets in benign prostatic hyperplasia
Zhenpeng Zhu, Xing Ji, Wenyuan Leng, Weimin Hu, Chunru Xu, Xiaoyu Li, Jinqin Qian, Cuijian Zhang, Jian Lin
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Figures1
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUrinary Bladder and Prostate Research · Prostate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research